Clinical Trial

Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2025 (before its estimated May 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational clinical study aims to investigate the incidence and risk factors of post-induction hypotension (PIH) in geriatric cancer patients undergoing surgery under general anesthesia. PIH is defined as a drop in mean arterial pressure of ≥30% from baseline or below 65 mmHg within the first 20 minutes after anesthesia induction, prior to surgical stimulation. The primary objective is to determine the frequency of PIH in elderly oncology patients. Secondary objectives include evaluating the association of PIH with age, ASA score, cancer type, oncological treatments (chemotherapy/radiotherapy), comorbidities, medication use, anemia, biochemical parameters, and preoperative perfusion index (PI) and pleth variability index (PVI). Findings from this study are expected to contribute to improved perioperative management and to the development of tailored anesthesia protocols for geriatric oncology patients.
Trial Details
NCT Number NCT07294040
Lead Sponsor Dolunay ARIK
Conditions Post-induction Hypotension (PIH), Geriatric Patient, Oncologic Disease, Hemodynamic Effects of General Anesthesia, Risk Factors Associated With Anesthesia-Induced Hypotension
Enrollment 140 participants
Start Date 2025-05-25
Primary Completion 2026-05-25 (estimated)
Study Completion 2026-05-25 (estimated)
Updated on ClinicalTrials.gov 2025-12-19